Alibaba's (BABA) Qwen team reportedly stable and will maintain open-source, and denies Qwen team mass departure
Newsquawk Staff ·
Alibaba's (BABA) Qwen team reportedly stable and will maintain open-source, and denies Qwen team mass departure.
What it means
The report on Alibaba's Qwen team maintaining stability and open-source efforts is a positive sign for investor sentiment, suggesting no significant disruptions in key operations. This alleviates potential concerns about talent drain and indicates Alibaba's commitment to its technological initiatives, which could support the stock price amid broader market movements.
- Newsquawk Daily US Equity Opening News - NVDA plans USD 3bln META investment; SOFI earnings impress
- US EQUITY OPEN: Mag-7 earnings lead Tech and Indices lower as the Middle East situation remains fragile
- Newsquawk Daily US Equity Opening News - TSLA & META fall after earnings; TSLA & SPCX said to target H1 2027 merger
- [MARKET ANALYSIS] European bourses suffer from the risk tone in Asia, as Tesla's cut in spending plans reignite AI worries
- ByteDance, Alibaba (BABA) and Tencent (0700 HK) have reportedly ordered in excess of 3mln NVIDIA (NVDA) RTX Pro 5500 workstation GPUs, with a combined value of more than USD 35bln, sources suggest
Related headlines
- EUROPEAN OPEN: SAP GY rises after earnings report; NOKIA FH Q3 profit/revenue beat; ROP SW Q3 sales top expectations; QIA GY agrees EUR 10.8bln EQT takeover; NESN SW Q3 organic sales growth beats; RMS FP Q3 revenue rises; BARC LN Q3 pretax profit rises6 days ago
- PRE-MARKET CHINESE STOCK NEWS: CATL Q3 profit misses; Tianqi Lithium and Yankuang flag sharp 9M profit gains; Montage Tech sees Q3 profit more than double7 days ago
- Newsquawk Daily US Opening News - 20th October 2026Oct 20
- Genmab (GMAB/GMAB DC) announced positive topline results from the global Phase 3 LiGeR-HN1 trial evaluating petosemtamab1 hour ago
- Eli Lilly’s (LLY) retatrutide delivered greater A1C reduction and more than double the weight loss of Novo Nordisk’s (NOVOB DC) Ozempic at its highest approved dose in head-to-head trial4 hours ago
- TPG pursues USD 5bln acquisition of UK data centre group Ark, according to FT9 hours ago
- Syngenta targets at least a USD 66bln valuation in Hong Kong IPO11 hours ago
- HP (HPQ), Asus (2357 TT) and Acer (2353 TT) are shifting some PC production from Thailand and Vietnam back to China to combat soaring component costs driven by AI-related memory and storage shortages, reports Nikkei citing sources19 hours ago
- Universal Music Group (UMG NA) discusses going private with buyout firms, according to Bloomberg1 day ago
- Japan's Sakana AI to build homegrown model to cut US and China reliance, reports Nikkei1 day ago
- Japan's Sakana AI to build homegrown model to cut US and China reliance, Nikkei reports1 day ago
- Foxconn (2317 TT) has brought online an AI factory powered by an NVIDIA (NVDA) DGX supercomputing cluster2 days ago
- US FDA has approved Novo's (NOVOB DC) once-weekly insulin treatment for paediatric patients with type 2 diabetes mellitus4 days ago
- Meta's (META) Muse AI to counter China models with subscribers, not ads, Nikkei reports4 days ago
- Toyota (TM) to recall 68k late model 2022-2024 Lexus NX vehicles in the US due to a display flaw4 days ago